Buccal absorption of ergotamine

15Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The rate of disappearance of ergotamine from the mouth after buccal administration has been studied in seven subjects. Allowance has been made for non-absorptive losses of the drug due to experimental technique. The absorption of ergotamine across the buccal mucosa appears to be a passive process, pH-dependent but independent of ergotamine concentration or the simultaneous presence of caffeine. Because of the low solubility of ergotamine at the pH of saliva, it is unlikely that therapeutically useful amounts of the drug would have absorbed across the buccal mucosa even after the drug had been in the mouth for five minutes.

Cite

CITATION STYLE

APA

Sutherland, J. M., Hooper, W. D., Eadie, M. J., & Tyrer, J. H. (1974). Buccal absorption of ergotamine. Journal of Neurology, Neurosurgery and Psychiatry, 37(10), 1116–1120. https://doi.org/10.1136/jnnp.37.10.1116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free